Emerald Health Therapeutics to Present at Rodman & Renshaw Investment Conference
VICTORIA, Sept. 6, 2017 /CNW/ - Emerald Health Therapeutics Inc. (TSXV: EMH; OCTQX: EMHTF) today announced that Dr. Bin Huang, President and CEO, will present an overview of the company at the Rodman & Renshaw 19th Annual Global Investment Conference.
Presentation:
4:40 PM ET, September 11, 2017
Kennedy II Room
Lotte New York Palace, New York, NY
Live and archived versions of the presentation will be available at this link.
Join us on our journey of making lives better through cannabis science.
Emerald Health Therapeutics Inc.
Emerald Health Therapeutics, Inc. (TSXV: EMH; OTCQX:EMHTF) operates primarily through Emerald Health Botanicals Inc. ("Botanicals"), a wholly owned subsidiary of the Company and a Licensed Producer under the Access to Cannabis for Medical Purposes Regulations (the "ACMPR"). Botanicals is authorized to produce and sell both dried medical cannabis flowers and medical cannabis oils in Canada. Botanicals currently operates an indoor facility in Victoria, British Columbia, with plans for expansion on a 32-acre property in Metro Vancouver and a joint venture with Village Farms utilizing a 25 acre existing greenhouse complex in Delta, BC. Botanicals is one of Canada's most medically focused licensed producers, with a team of highly qualified management experienced in life sciences drug development and large-scale agribusiness. Emerald's vision is to be a leading provider of cannabis products through its production capabilities, proprietary genetics and intellectual property, value-added products and branding, and superb customer experience. Emerald is part of the Emerald Health family of companies which is seeking to enhance health and well-being through diverse investments that advance the development of cannabis for pharmaceutical, botanical and bioceutical applications.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements. Emerald Health Therapeutics Inc. does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law.
SOURCE Emerald Health Therapeutics, Inc.
Sandy Pratt, CFO, Emerald Health Therapeutics, [email protected]
Share this article